These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 11834884
1. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation. Umeda N, Ozaki H, Hayashi H, Kondo H, Uchida H, Oshima K. Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884 [Abstract] [Full Text] [Related]
2. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders. Katsura Y, Okano T, Noritake M, Kosano H, Nishigori H, Kado S, Matsuoka T. Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744 [Abstract] [Full Text] [Related]
3. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Simó R, Lecube A, Segura RM, García Arumí J, Hernández C. Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249 [Abstract] [Full Text] [Related]
4. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N. Ophthalmic Res; 2012 Sep; 47(1):7-12. PubMed ID: 21691136 [Abstract] [Full Text] [Related]
5. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy. Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Uchita M, Matsuzaki T, Takayama M, Shinmura K, Yamada M. Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602 [Abstract] [Full Text] [Related]
6. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M. Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245 [Abstract] [Full Text] [Related]
7. Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy. Hattenbach LO, Allers A, Gümbel HO, Scharrer I, Koch FH. Retina; 1999 Sep; 19(5):383-9. PubMed ID: 10546932 [Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE. N Engl J Med; 1994 Dec 01; 331(22):1480-7. PubMed ID: 7526212 [Abstract] [Full Text] [Related]
9. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H. Am J Ophthalmol; 2005 Mar 01; 139(3):476-81. PubMed ID: 15767056 [Abstract] [Full Text] [Related]
10. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin. Noma H, Funatsu H, Yamashita H, Kitano S, Mishima HK, Hori S. Arch Ophthalmol; 2002 Aug 01; 120(8):1075-80. PubMed ID: 12149062 [Abstract] [Full Text] [Related]
11. Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy. Hernández C, Lecube A, Segura RM, Sararols L, Simó R. Diabet Med; 2002 Aug 01; 19(8):655-60. PubMed ID: 12147146 [Abstract] [Full Text] [Related]
12. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy]. Zhou H, Zhang H. Zhonghua Yan Ke Za Zhi; 1997 Jul 01; 33(4):247-50. PubMed ID: 10451953 [Abstract] [Full Text] [Related]
13. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H. Ophthalmology; 2008 Nov 01; 115(11):1916-22. PubMed ID: 18718666 [Abstract] [Full Text] [Related]
14. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. Nishimura M, Ikeda T, Ushiyama M, Nanbu A, Kinoshita S, Yoshimura M. J Clin Endocrinol Metab; 1999 Feb 01; 84(2):659-62. PubMed ID: 10022434 [Abstract] [Full Text] [Related]
15. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Deng J, Wu DZ, Gao R. Yan Ke Xue Bao; 1999 Mar 01; 15(1):17-21. PubMed ID: 12579655 [Abstract] [Full Text] [Related]
16. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Matsuzaki T, Takayama M, Shinmura K, Yamada M. Br J Ophthalmol; 1999 Jul 01; 83(7):834-7. PubMed ID: 10381671 [Abstract] [Full Text] [Related]
17. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Itakura H, Kishi S, Kotajima N, Murakami M. Ophthalmology; 2004 Oct 01; 111(10):1880-4. PubMed ID: 15465550 [Abstract] [Full Text] [Related]
18. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. Mohan N, Monickaraj F, Balasubramanyam M, Rema M, Mohan V. J Diabetes Complications; 2012 Oct 01; 26(5):435-41. PubMed ID: 22699109 [Abstract] [Full Text] [Related]